Cingulate Inc. Warrants

YTD

ALL

Why Robinhood?

You can watch CINGW and buy or sell other stocks, ETFs, and their options commission-free!

About CINGW

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).

CEO

Shane J. Schaffer, PharmD

CEOShane J. Schaffer, PharmD

Employees

—

Employees—

Headquarters

Kansas City, Kansas

HeadquartersKansas City, Kansas

Founded

2013

Founded2013

Employees

—

Employees—

CINGW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

54.66K

Average volume54.66K

High today

$0.10

High today$0.10

Low today

$0.0436

Low today$0.0436

Open price

$0.0469

Open price$0.0469

Volume

415.35K

Volume415.35K

52 Week high

$0.18

52 Week high$0.18

52 Week low

$0.008

52 Week low$0.008